TP53 and hepatocellular carcinoma: Previous studies have shown that TsIIA can not only inhibit the expression of CDK in HCC cells but also increase the activation and expression of CDK inhibition (p21, p27, p16) by promoting p53 and miR30b-p53 PTPN11/SHP2-mediated methods (80).